Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study.

Raffi F, Rachlis A, Stellbrink HJ, Hardy WD, Torti C, Orkin C, Bloch M, Podzamczer D, Pokrovsky V, Pulido F, Almond S, Margolis D, Brennan C, Min S; SPRING-2 Study Group..

Lancet. 2013 Mar 2;381(9868):735-43. doi: 10.1016/S0140-6736(12)61853-4. Epub 2013 Jan 8.

PMID:
23306000
2.

Abacavir/dolutegravir/lamivudine single-tablet regimen: a review of its use in HIV-1 infection.

Greig SL, Deeks ED.

Drugs. 2015 Apr;75(5):503-14. doi: 10.1007/s40265-015-0361-6. Review. Erratum in: Drugs. 2015 Apr;75(5):561.

PMID:
25698454
3.

Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.

Rathbun RC, Lockhart SM, Miller MM, Liedtke MD.

Ann Pharmacother. 2014 Mar;48(3):395-403. doi: 10.1177/1060028013513558. Epub 2013 Nov 19. Review.

PMID:
24259658
4.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
5.

Dolutegravir for the treatment of adult patients with HIV-1 infection.

Wu G, Abraham T, Saad N.

Expert Rev Anti Infect Ther. 2014 May;12(5):535-44. doi: 10.1586/14787210.2014.907525. Epub 2014 Apr 2. Review.

PMID:
24694091
6.

Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV.

Shah BM, Schafer JJ, Desimone JA Jr.

Pharmacotherapy. 2014 May;34(5):506-20. doi: 10.1002/phar.1386. Epub 2013 Dec 18. Review. Erratum in: Pharmacotherapy. 2014 Jun;34(6):667.

PMID:
24347095
7.

[Efficacy of dolutegravir in treatment-experienced patients: the SAILING and VIKING trials].

Moreno S, Berenguer J.

Enferm Infecc Microbiol Clin. 2015 Mar;33 Suppl 1:26-30. doi: 10.1016/S0213-005X(15)30006-9. Review. Spanish.

PMID:
25858609
8.

[Integrase inhibitors - new challenges for the treatment of HIV-1 infections].

Stock I.

Med Monatsschr Pharm. 2013 Dec;36(12):448-59; quiz 461-2. Review. German.

PMID:
24450269
9.

Dolutegravir: a review of its use in the management of HIV-1 infection in adolescents and adults.

McCormack PL.

Drugs. 2014 Jul;74(11):1241-52. doi: 10.1007/s40265-014-0256-y. Review.

PMID:
25005775
10.

Update on raltegravir and the development of new integrase strand transfer inhibitors.

Shamroe CL, Bookstaver PB, Rokas KE, Weissman SB.

South Med J. 2012 Jul;105(7):370-8. doi: 10.1097/SMJ.0b013e318258c847. Review.

PMID:
22766666
11.

Raltegravir: in treatment-naive patients with HIV-1 infection.

Croxtall JD, Scott LJ.

Drugs. 2010 Mar 26;70(5):631-42. doi: 10.2165/11204590-000000000-00000. Review.

PMID:
20329808
12.

The use of HIV-1 integrase inhibitors in antiretroviral naive patients.

Lennox JL.

Curr Opin HIV AIDS. 2012 Sep;7(5):409-14. doi: 10.1097/COH.0b013e3283562a27. Review.

PMID:
22789985
13.

[Efficacy of dolutegravir in treatment-naïve patients. The SPRING-1, SPRING-2, SINGLE and FLAMINGO trials].

Bernardino JI, Antela A.

Enferm Infecc Microbiol Clin. 2015 Mar;33 Suppl 1:14-9. doi: 10.1016/S0213-005X(15)30004-5. Review. Spanish.

PMID:
25858607
14.

First-line raltegravir. No evidence of comparative effectiveness.

[No authors listed]

Prescrire Int. 2010 Nov;19(110):248-50. Review.

PMID:
21284354
15.

Dolutegravir: a next-generation integrase inhibitor for treatment of HIV infection.

Osterholzer DA, Goldman M.

Clin Infect Dis. 2014 Jul 15;59(2):265-71. doi: 10.1093/cid/ciu221. Epub 2014 Apr 9. Review.

PMID:
24723281
16.

Resistance analyses of integrase strand transfer inhibitors within phase 3 clinical trials of treatment-naive patients.

White KL, Raffi F, Miller MD.

Viruses. 2014 Jul 22;6(7):2858-79. doi: 10.3390/v6072858. Review.

17.

Efficacy and Tolerability of Integrase Inhibitors in Antiretroviral-Naive Patients.

D'Abbraccio M, Busto A, De Marco M, Figoni M, Maddaloni A, Abrescia N.

AIDS Rev. 2015 Jul-Sep;17(3):171-85. Review.

PMID:
26450805
18.

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Taiwo B, Murphy RL, Katlama C.

Drugs. 2010 Sep 10;70(13):1629-42. doi: 10.2165/11538020-000000000-00000. Review.

PMID:
20731472
19.

[Position of dolutegravir in the treatment of HIV infection].

Martínez E, Gatell JM.

Enferm Infecc Microbiol Clin. 2015 Mar;33 Suppl 1:31-3. doi: 10.1016/S0213-005X(15)30007-0. Review. Spanish.

PMID:
25858610
20.

Pharmacology of HIV integrase inhibitors.

Adams JL, Greener BN, Kashuba AD.

Curr Opin HIV AIDS. 2012 Sep;7(5):390-400. doi: 10.1097/COH.0b013e328356e91c. Review.

Supplemental Content

Support Center